Long COVID Trial, Recruiting NCT07134673 Sponsor: Universitair Ziekenhuis Brussel Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT07134673
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

For people with Long COVID:

Who might be able to join this trial:

  • You have been diagnosed with Long COVID, based on the World Health Organization's definition.
  • You have been experiencing Long COVID symptoms for at least 6 months.
  • You have a confirmed or documented record of having had COVID-19.
  • You are 18 years of age or older.
  • Before COVID-19 you had no limitations in daily life, but since then you have had some level of ongoing functional difficulty (confirm with trial site for exact scoring details).

Who may not be able to join:

  • You have a long-term illness that was already affecting your daily functioning before COVID-19.
  • You are currently taking medications that affect how your body processes substances (confirm with trial site).
  • You drink more than 10 standard glasses of alcohol per week (where one standard glass contains 10 grams of alcohol).
  • You are unable to read or understand spoken and written instructions in Dutch, French, or English.
  • You have an allergy to medical sticky/adhesive bandages or plasters.
  • You have porphyria or another skin condition that gets worse with sunlight exposure.

For people who have fully recovered from COVID-19:

Who might be able to join this trial:

  • You have a confirmed or documented record of having had COVID-19.
  • You have fully recovered from COVID-19 and have never had Long COVID, based on the World Health Organization's definition.
  • You had no limitations in daily life before COVID-19 and still have none today (confirm with trial site for exact scoring details).
  • You are 18 years of age or older.

Who may not be able to join:

  • You have a pre-existing long-term condition such as high blood pressure, chronic breathing problems, or diabetes.
  • You are currently taking medications that affect how your body processes substances (confirm with trial site).
  • You drink more than 10 standard glasses of alcohol per week (where one standard glass contains 10 grams of alcohol).
  • You are unable to read or understand spoken and written instructions in Dutch, French, or English.
  • You have an allergy to medical sticky/adhesive bandages or plasters.
  • You have porphyria or another skin condition that gets worse with sunlight exposure.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elisabeth De Waele, MD. PhD., Vitality Research Group, Metabolism and Nutrition, Vrije Universiteit Brussel (VUB), Clinical Nutrition Department, Universitair Ziekenhuis Brussel (UZ Brussel)

Phone: +3224749624

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
21 January 2026
Est. completion
1 July 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Basal Oxygen Consumption rate (pmol O2/min); Tissue Saturation Index (TSI); Mitochondrial oxygen tension (mitoPO2) (mmHg/s); Mitochondrial oxygen consumption (mitoVO2)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov